vs

Side-by-side financial comparison of NEWMARK GROUP, INC. (NMRK) and STEPAN CO (SCL). Click either name above to swap in a different company.

NEWMARK GROUP, INC. is the larger business by last-quarter revenue ($859.5M vs $604.5M, roughly 1.4× STEPAN CO). NEWMARK GROUP, INC. runs the higher net margin — 7.9% vs 3.3%, a 4.6% gap on every dollar of revenue. On growth, NEWMARK GROUP, INC. posted the faster year-over-year revenue change (18.1% vs 1.9%). Over the past eight quarters, NEWMARK GROUP, INC.'s revenue compounded faster (38.2% CAGR vs 4.2%).

Newmark Group Inc. is a global commercial real estate advisory and services firm headquartered in New York City. It operates as Newmark, and is listed on the NASDAQ Global Select Market under the symbol "NMRK".

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

NMRK vs SCL — Head-to-Head

Bigger by revenue
NMRK
NMRK
1.4× larger
NMRK
$859.5M
$604.5M
SCL
Growing faster (revenue YoY)
NMRK
NMRK
+16.2% gap
NMRK
18.1%
1.9%
SCL
Higher net margin
NMRK
NMRK
4.6% more per $
NMRK
7.9%
3.3%
SCL
Faster 2-yr revenue CAGR
NMRK
NMRK
Annualised
NMRK
38.2%
4.2%
SCL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NMRK
NMRK
SCL
SCL
Revenue
$859.5M
$604.5M
Net Profit
$68.0M
$19.7M
Gross Margin
10.7%
Operating Margin
14.4%
4.7%
Net Margin
7.9%
3.3%
Revenue YoY
18.1%
1.9%
Net Profit YoY
49.7%
EPS (diluted)
$0.37
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NMRK
NMRK
SCL
SCL
Q1 26
$604.5M
Q4 25
$859.5M
$553.9M
Q3 25
$715.0M
$590.3M
Q2 25
$639.6M
$594.7M
Q1 25
$556.2M
$593.3M
Q4 24
$727.5M
$525.6M
Q3 24
$568.0M
$546.8M
Q2 24
$527.3M
$556.4M
Net Profit
NMRK
NMRK
SCL
SCL
Q1 26
$19.7M
Q4 25
$68.0M
$5.0M
Q3 25
$46.2M
$10.8M
Q2 25
$20.8M
$11.3M
Q1 25
$-8.8M
$19.7M
Q4 24
$45.4M
$3.4M
Q3 24
$17.8M
$23.6M
Q2 24
$14.3M
$9.5M
Gross Margin
NMRK
NMRK
SCL
SCL
Q1 26
10.7%
Q4 25
9.3%
Q3 25
12.0%
Q2 25
12.1%
Q1 25
12.7%
Q4 24
10.8%
Q3 24
13.8%
Q2 24
12.5%
Operating Margin
NMRK
NMRK
SCL
SCL
Q1 26
4.7%
Q4 25
14.4%
1.9%
Q3 25
11.9%
3.7%
Q2 25
6.7%
3.0%
Q1 25
-3.1%
4.8%
Q4 24
14.3%
1.5%
Q3 24
7.2%
4.4%
Q2 24
7.7%
3.4%
Net Margin
NMRK
NMRK
SCL
SCL
Q1 26
3.3%
Q4 25
7.9%
0.9%
Q3 25
6.5%
1.8%
Q2 25
3.3%
1.9%
Q1 25
-1.6%
3.3%
Q4 24
6.2%
0.6%
Q3 24
3.1%
4.3%
Q2 24
2.7%
1.7%
EPS (diluted)
NMRK
NMRK
SCL
SCL
Q1 26
$0.86
Q4 25
$0.37
$0.22
Q3 25
$0.25
$0.47
Q2 25
$0.11
$0.50
Q1 25
$-0.05
$0.86
Q4 24
$0.25
$0.14
Q3 24
$0.10
$1.03
Q2 24
$0.08
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NMRK
NMRK
SCL
SCL
Cash + ST InvestmentsLiquidity on hand
$229.1M
Total DebtLower is stronger
$671.7M
$328.4M
Stockholders' EquityBook value
$1.5B
$1.2B
Total Assets
$5.0B
$2.3B
Debt / EquityLower = less leverage
0.46×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NMRK
NMRK
SCL
SCL
Q1 26
Q4 25
$229.1M
$132.7M
Q3 25
$224.1M
$118.5M
Q2 25
$195.8M
$88.9M
Q1 25
$157.1M
$107.5M
Q4 24
$197.7M
$99.7M
Q3 24
$178.6M
$147.3M
Q2 24
$176.4M
$124.7M
Total Debt
NMRK
NMRK
SCL
SCL
Q1 26
$328.4M
Q4 25
$671.7M
$626.7M
Q3 25
$746.5M
$655.5M
Q2 25
$871.2M
$658.0M
Q1 25
$770.9M
$659.3M
Q4 24
$670.7M
$625.4M
Q3 24
$770.4M
$688.5M
Q2 24
$745.2M
$657.1M
Stockholders' Equity
NMRK
NMRK
SCL
SCL
Q1 26
$1.2B
Q4 25
$1.5B
$1.2B
Q3 25
$1.4B
$1.2B
Q2 25
$1.3B
$1.2B
Q1 25
$1.3B
$1.2B
Q4 24
$1.2B
$1.2B
Q3 24
$1.2B
$1.2B
Q2 24
$1.2B
$1.2B
Total Assets
NMRK
NMRK
SCL
SCL
Q1 26
$2.3B
Q4 25
$5.0B
$2.4B
Q3 25
$5.5B
$2.4B
Q2 25
$5.4B
$2.4B
Q1 25
$4.8B
$2.4B
Q4 24
$4.7B
$2.3B
Q3 24
$5.0B
$2.4B
Q2 24
$4.8B
$2.3B
Debt / Equity
NMRK
NMRK
SCL
SCL
Q1 26
0.28×
Q4 25
0.46×
0.50×
Q3 25
0.55×
0.53×
Q2 25
0.68×
0.53×
Q1 25
0.58×
0.55×
Q4 24
0.56×
0.53×
Q3 24
0.66×
0.56×
Q2 24
0.62×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NMRK
NMRK
SCL
SCL
Operating Cash FlowLast quarter
$618.5M
Free Cash FlowOCF − Capex
$608.8M
FCF MarginFCF / Revenue
70.8%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
9.10×
TTM Free Cash FlowTrailing 4 quarters
$142.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NMRK
NMRK
SCL
SCL
Q1 26
Q4 25
$618.5M
$60.0M
Q3 25
$112.6M
$69.8M
Q2 25
$-379.7M
$11.2M
Q1 25
$-179.4M
$6.9M
Q4 24
$402.6M
$68.3M
Q3 24
$-85.2M
$22.7M
Q2 24
$-258.5M
$29.5M
Free Cash Flow
NMRK
NMRK
SCL
SCL
Q1 26
Q4 25
$608.8M
$25.4M
Q3 25
$104.9M
$40.2M
Q2 25
$-386.2M
$-14.4M
Q1 25
$-184.8M
$-25.8M
Q4 24
$396.6M
$32.1M
Q3 24
$-94.4M
$-4.0M
Q2 24
$-267.8M
$-208.0K
FCF Margin
NMRK
NMRK
SCL
SCL
Q1 26
Q4 25
70.8%
4.6%
Q3 25
14.7%
6.8%
Q2 25
-60.4%
-2.4%
Q1 25
-33.2%
-4.3%
Q4 24
54.5%
6.1%
Q3 24
-16.6%
-0.7%
Q2 24
-50.8%
-0.0%
Capex Intensity
NMRK
NMRK
SCL
SCL
Q1 26
Q4 25
1.1%
6.3%
Q3 25
1.1%
5.0%
Q2 25
1.0%
4.3%
Q1 25
1.0%
5.5%
Q4 24
0.8%
6.9%
Q3 24
1.6%
4.9%
Q2 24
1.8%
5.3%
Cash Conversion
NMRK
NMRK
SCL
SCL
Q1 26
Q4 25
9.10×
11.99×
Q3 25
2.44×
6.44×
Q2 25
-18.24×
0.99×
Q1 25
0.35×
Q4 24
8.86×
20.38×
Q3 24
-4.79×
0.96×
Q2 24
-18.10×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NMRK
NMRK

Management Services$263.1M31%
Investment Advice$200.1M23%
Mortgage Brokerage And Debt Placement$83.1M10%
Servicing Fees And Other$80.7M9%
GB$69.0M8%
Other Geographical Areas$63.6M7%
Servicing$36.2M4%
Other$34.2M4%
Loan Originations Related Fees And Sales Premiums Net$29.6M3%

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

Related Comparisons